News | Stents Drug Eluting | January 26, 2021

FDA Clears Boston Scientific Synergy Megatron Drug-eluting Stent for Proximal, Fibrotic and Calcified Lesions

FDA Clears Boston Scientific Synergy Megatron Drug-eluting Stent for Proximal, Fibrotic and Calcified Lesions

January 26, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Boston Scientific's Synergy Megatron Drug-Eluting Stent (DES) system. The company said it is the first platform that is purpose-built for large, proximal vessels.

Interventional cardiologists voiced an unmet need for a DES designed to treat large, proximal vessels – those that are closest to the aorta. These vessels can present unique challenges for cardiologists and Boston Scientific said the Synergy Megatron provides best-in-class radial and axial strength to maintain stent integrity. The stent also allows the largest over-expansion range on the market, which helps the device fit within tapered vessels. 

The stent is designed for higher strength applications in proximal, fibrotic and calcified lesions. With its ability to be over-expanded, it can accommodate wider diameter mismatches as the vessel tapers, helping maximize lumen gain. 

It also is built with a proprietary platinum chromium alloy, which is highly visible on angiography, which can help with accurate stent placement.
 
The stent is available in 3.5 - 5 mm diameters.

For more information: https://www.bostonscientific.com/en-US/products/stents--coronary/synergy-megatron.html

Find more cath lab technology news


Additional Content

News | Cath Lab

Nov. 2, 2026 — Royal Philips has announced U.S. commercial availability of the HyperVue Integrated System1, a new single ...

Home November 03, 2026
Home
News | Cath Lab

Aug. 28, 2026 — Heartflow, Inc. has announced late-breaking one-year results from an independent randomized clinical ...

Home August 28, 2026
Home
News | Cath Lab

July 9, 2026 — On July 9, Stereotaxis announced that it has completed its previously announced acquisition of Robocath ...

Home July 10, 2026
Home
News | Cath Lab

June 18, 2026 — Allegheny Health Network's (AHN) Allegheny General Hospital (AGH) has completed a $19 million renovation ...

Home June 18, 2026
Home
News | Cath Lab

May 28, 2026 — RWJBarnabas Health has earned Cardiac Catheterization Lab Accreditation from the American College of ...

Home May 29, 2026
Home
Subscribe Now